KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $713,000 | +88.6% | 3,967 | +8.7% | 0.00% | +33.3% |
| Q2 2017 | $378,000 | +34.0% | 3,651 | +1.4% | 0.00% | +50.0% |
| Q1 2017 | $282,000 | +16.0% | 3,599 | -17.3% | 0.00% | 0.0% |
| Q3 2016 | $243,000 | -9.3% | 4,352 | -18.9% | 0.00% | 0.0% |
| Q2 2016 | $268,000 | +24.1% | 5,364 | +13.8% | 0.00% | +100.0% |
| Q1 2016 | $216,000 | +29.3% | 4,713 | +73.8% | 0.00% | 0.0% |
| Q4 2015 | $167,000 | -12.6% | 2,711 | -21.0% | 0.00% | -50.0% |
| Q3 2015 | $191,000 | +193.8% | 3,432 | +221.0% | 0.00% | – |
| Q2 2015 | $65,000 | -93.7% | 1,069 | -94.0% | 0.00% | -100.0% |
| Q1 2015 | $1,028,000 | +5947.1% | 17,818 | +6044.1% | 0.01% | – |
| Q4 2014 | $17,000 | – | 290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |